The First Heart Transplant: Christiaan Barnard's 1967 Operation That Shocked the World

The Science That Made It Possible

The heart transplant did not arrive without preparation. By the time Barnard performed his operation at Groote Schuur Hospital in Cape Town, the theoretical groundwork had been laid over decades of research. Norman Shumway at Stanford University had been working on cardiac transplantation in animals since the late 1950s and had developed much of the surgical technique that Barnard adapted. Adrian Kantrowitz in New York had transplanted dog hearts. The immunosuppressive drugs that might allow a recipient's immune system to tolerate a foreign organ — particularly azathioprine — had been developed in the early 1960s in the context of kidney transplantation.

Barnard had visited Shumway's laboratory and studied the technique. He had also trained at the University of Minnesota, where the heart-lung bypass machine — essential for keeping a patient alive while the heart is stopped — had been developed by Walton Lillehei and John Lewis. The technological preconditions were assembled; what was required was a surgeon willing to make the leap from animal experimentation to a human patient. Barnard decided he was ready in late 1967, and when a suitable donor and recipient presented themselves simultaneously, he operated.

The Operation

The recipient was Louis Washkansky, a 54-year-old wholesale grocer dying of congestive heart failure, who agreed to the operation knowing the risks were enormous and the outcome entirely uncertain. The donor was Denise Darvall, a 25-year-old woman who had been fatally injured in a car accident. After Darvall was declared brain dead, her family consented to the donation of her heart, and the operation began at midnight on December 3rd.

Barnard led a team of thirty people in nine hours of surgery. Washkansky was placed on heart-lung bypass, his failing heart was removed, and Darvall's heart was sewn into his chest cavity and connected to his blood vessels. When Barnard restarted the transplanted heart with an electric shock, it began to beat. "The heart went into ventricular fibrillation," Barnard later recalled. "We gave it a little shock and it went into a beautiful normal rhythm." Washkansky regained consciousness and could speak to his family. The surgery had worked.

Eighteen Days and What They Meant

Washkansky survived for eighteen days after the transplant. He died not from rejection of the transplanted heart but from bilateral pneumonia — his immunosuppression, designed to prevent rejection, had left him vulnerable to infection. His death was a setback but not a refutation: his heart was functioning well at the time he died. The medical establishment recognized that the fundamental challenge of transplantation — keeping the transplanted organ alive — had been met. The next problems were immunological and infectious, and those, unlike the surgical technique, were addressable.

Barnard performed a second transplant the following January on a patient named Philip Blaiberg, who survived for 594 days. The era of cardiac transplantation had genuinely begun. By the end of 1968, over a hundred heart transplants had been performed worldwide by teams that had been watching and preparing. The initial results were poor — most patients died within weeks or months — and a period of retrenchment followed in the early 1970s as the field grappled with rejection. The development of cyclosporine as an immunosuppressant in the early 1980s transformed outcomes dramatically, and heart transplantation became a routine, if demanding, procedure.

The Ethics and the Legacy

The 1967 operation also raised profound ethical questions that the medical world had not fully grappled with. The concept of brain death — the idea that a person could be considered legally and medically dead while their heart was still beating with mechanical assistance — was central to cardiac transplantation: you needed a heart that had been perfused with oxygenated blood until moments before removal. Darvall's heart was still beating when Barnard removed it. The legal and medical frameworks for defining death had to evolve to accommodate this new surgical reality, and the debates that Barnard's operation triggered about when life ends and what the dying owe to the living have not been entirely resolved to this day. His operation did not merely push the boundaries of surgery — it pushed the boundaries of how humanity thinks about life, death, and the body's relationship to personhood.